| Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524404 |
NSE Symbol : MARKSANS |
P/E(TTM) : 40.77 |
|
ISIN Demat : INE750C01026 |
Div & Yield% : 0.33 |
EPS(TTM) : 6.60 |
|
Book Value(₹) : 36.46 |
Market Cap(₹Cr) : 12,192.37 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,341.48 | 1,174.37 | 853.27 | 655.20 | 658.29 |
| Other Income | 103.53 | 65.79 | 62.07 | 60.48 | 42.25 |
| Stock Adjustments | -3.30 | -0.70 | 7.25 | 10.19 | -3.89 |
| Total Income | 1,441.71 | 1,239.46 | 922.59 | 725.87 | 696.65 |
| EXPENDITURE : | |||||
| Raw Materials | 675.49 | 639.24 | 486.18 | 404.64 | 373.70 |
| Power and Fuel Cost | 32.95 | 30.73 | 26.04 | 14.24 | 11.49 |
| Other Manufacturing Expenses | 65.94 | 64.62 | 46.10 | 21.09 | 5.25 |
| Selling and Administration Expenses | 96.71 | 112.99 | 73.19 | 61.54 | 67.57 |
| Miscellaneous Expenses | 21.55 | 16.32 | 11.88 | 15.89 | 22.22 |
| Employee Benefit Expenses | 121.98 | 101.68 | 77.19 | 56.09 | 60.46 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 427.10 | 273.88 | 202.01 | 152.38 | 155.97 |
| Interest | 1.33 | 1.17 | 0.99 | 3.61 | 3.80 |
| Gross Profit | 425.77 | 272.71 | 201.02 | 148.77 | 152.17 |
| Depreciation | 34.23 | 29.45 | 29.13 | 16.74 | 17.66 |
| Profit Before Tax | 391.54 | 243.26 | 171.89 | 132.03 | 134.51 |
| Current Tax | 86.29 | 52.14 | 37.46 | 29.34 | 30.02 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.55 | 2.84 | 0.68 | -0.17 | 0.50 |
| Reported Net Profit | 300.70 | 188.27 | 133.76 | 102.87 | 103.99 |
| Extraordinary Items | 1.43 | 0.81 | 0.07 | -0.05 | 0.00 |
| Adjusted Net Profit | 299.27 | 187.46 | 133.69 | 102.92 | 103.99 |
| Adjustment below Net Profit | 1.04 | -0.30 | 0.28 | -8.64 | 0.05 |
| Profit/Loss Balance carried down | 505.78 | 345.00 | 233.61 | 155.21 | 61.41 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 36.25 | 27.19 | 22.66 | 15.82 | 10.23 |
| P & L Balance carried down | 771.26 | 505.78 | 345.00 | 233.61 | 155.21 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 90.00 | 80.00 | 60.00 | 50.00 | 25.00 |
| Dividend Per Share(Rs) | 0.90 | 0.80 | 0.60 | 0.50 | 0.25 |
| Earnings Per Share-Unit Curr | 6.64 | 4.15 | 2.95 | 2.27 | 2.54 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 36.46 | 30.53 | 26.98 | 24.52 | 16.90 |
| Book Value(Adj)-Unit Curr | 36.46 | 30.53 | 26.98 | 24.52 | 16.90 |
